HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS
key details
| Status | complete |
|---|---|
| Category (CPV) | 33141530 |
| Region | West Midlands |
| Deadline | 30 Jun 2017 |
| Contract start | 1 Jul 2017 |
| Contract end | 30 Jun 2018 |
| SME suitable | No |
| OCID | ocds-b5fd17-728a04cb-e500-457a-83eb-10d01924a5da |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Healthcare at Home Ltd | £1,100,000 | 30 Jun 2017 | active |
description
HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS.
AWARDED AGAINST CMU FRAMEWORK REF CM/MSR/10/5222
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 5 Jul 2017 | Award (award) | · | c253316d-5309-4c40-aa74-6a5d0c01b0be-158436 |
more from University Hospitals of North Midlands NHS Trust
- Provision of Staffing Neurophysiology Outpatient Capacity on Evenings and Weekends within the Royal Stoke University Hospital (RSUH) Neurophysiology Department · 10 Jul 2026
- Provision of Perfusion Services to Deliver Core Cardiac Theatre Activity · 23 Apr 2026
- WHPC00945 · £341,279 · 29 Aug 2025
- WHPC00922 · £729,052 · 29 Aug 2025
- MED2171 - Collagen Fleece · £56,240 · 31 Jul 2025
- MED0118 - Embolectomy Catheters · £87,263 · 31 Jul 2025
- MED3027 - Procedure Packs · £102,500 · 11 Jul 2025
- MED2016 - Super Absorbent Tray Liners · £58,378 · 4 Jul 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Purchase of Diathermy · Leeds Teaching Hospitals NHS Trust · £48,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £130,000
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B · NHS England · £192,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £44,601
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders · NHS England · £302,000,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.